Press Releases

Edison, NJ, December 2016

MTF Wound Care’s AmnioBand® and AlloPatch® Pliable Receive the American Podiatric Medical Association Seal of Approval

Edison, NJ, December 14, 2016 /PRNewswire/ – After evaluating each MTF Wound Care allograft in several areas – including safety, quality and effectiveness – a panel of podiatric physicians from the American Podiatric Medical Association (APMA) has granted MTF Wound Care their Seal of Approval for its AmnioBand® family of placental allografts and AlloPatch® Pliable tissue

READ FULL ARTICLE >>

Edison, NJ, September 2015

MTF’s AmnioBand™ Receives High-Tier Reimbursement from Medicare to Treat Chronic Non-Healing Wounds in the Hospital Outpatient Setting

MTF, the Musculoskeletal Transplant Foundation (www.mtf.org) announced today that beginning October 1, AmnioBand™ Allograft Placental Matrix will be placed in the high-tier reimbursement category for skin substitutes under the Centers for Medicare and Medicaid Services’ (CMS) Hospital Outpatient Prospective Payment System.  With this designation hospital outpatient departments and affiliated wound care centers may now be

READ FULL ARTICLE >>

Edison, NJ, January 2015

MTF Signs Purchasing Agreement with Premier

The Musculoskeletal Transplant Foundation (MTF) Wound Care division announced today the signing of a group purchasing agreement with Premier, Inc.

READ FULL ARTICLE >>

Edison, NJ, December 2014

MTF Forms New Wound Care Division to Meet Growing Medical Need

The Musculoskeletal Transplant Foundation (MTF) announced today the launch of MTF Wound Care—a new MTF division dedicated to researching, developing and providing allograft-based, biologic solutions to treat acute and chronic wounds. MTF Wound care is a natural extension of MTF—the non-profit is the nation’s leading tissue bank supplying specialty donated human tissue for orthopedics, spine,

READ FULL ARTICLE >>